References
- 1. LI S., HONG M., TAN H., WANG N., FENG Y. Insights into the role and interdependence of oxidative stress in inflammation in liver diseases. Oxid Med Cell Longev. 2016; 2016:4234061.
- 2. ZHAN Y., AN W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol. 2010; 16(37):4652–4660.
- 3. LIU Y., ZHONG G., TAN H., HAO F., HU J. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta analysis. Sci Rep. 2019; 9:11124.
- 4. KUMAR A., SINGH AK., PANDA PK., NISCHAL N., SONEJA M. Non-alcoholic fatty liver disease diagnosis, grading and staging; a simplified tool for clinicians. JAM. 2017; 6(1):15–22.
- 5. LUCI C., VIEIRA E., PERCHET T., GUAL P., GOLUB R. Natural killer cells and type 1 innate lymphoid cells are new actors in non-alcoholic fatty liver disease. Front Immunol. 2019; 10:1192.
- 6. HAMMERICH L, TACKE F. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014;7:297–306.
- 7. HAMMERICH L., TACKE F. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014; 7:297–306.
- 8. ARRESE M., CABRERA D., KALERGIS AM., FELDSTEIN AE. Innate immunity and inflammation in NAFLD/NASH. Dig Dis Sci. 2016; 61(5):1294–1303.
- 9. GILES DA., MORENO-FERNANDEZ ME., DIVANOVIC S. IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression. Curr Drug Targets. 2015; 16(12):1315–1323.
- 10. DASARATHY S., DASARATHY S., KHIYAMI A., JOSEPH R., LOPEZ R., MCCULLOUGH AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009; 51(6):1061–1067.
- 11. SHANNON A., ALKHOURI N., CARTER-KENT C., MONTI L., DEVITO R., LOPEZ R., et al. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J Pediatr Gastroenterol Nutr. 2011; 53(2):190–195.
- 12. YOUNOSSI ZM., KOENIG AB., ABDELATIF D., FAZEL Y., HENRY L., WYMER M. Global epidemiology of nonalcoholic fatty liver disease – meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64(1):73–84.
- 13. DYSON JK., ANSTEE QM., MCPHERSON S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014; 5(3):211–218.
- 14. JENNISON E., PATEL J., SCORLETTI E., BYRNE CD. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J. 2019; 95(1124):314–322.
- 15. SANNA C., ROSSO C., MARIETTI M., BUGIANESI E. Non-alcoholic fatty liver disease and extra-hepatic cancers. Int J Mol Sci. 2016; 17(5):717.
- 16. STOJSAVLJEVIC S., PALCIC MG., JUKIC LV., DUVNJAK LS, DUVNJAK M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(48):18070–18091.
- 17. SUTTI S., ALBANO E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol. 2020; 17(2):81–92.
- 18. BRAUNERSREUTHER V., VIVIANI GL., MACH F., MONTECUCCO F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol. 2012; 18(8):727–735.
- 19. KREMER M., THOMAS E., MILTON RJ., PERRY AW., VAN ROOIJEN N., WHEELER MD. Kupffer cell and interleukin-12 dependent loss of natural killer T cells in hepatosteatosis. Hepatology. 2010; 51(1):130–141.
- 20. AJMERA V., PERITO ER., BASS NM., TERRAULT NA., YATES KP., GILL R., et al. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017; 65(1):65–77.
- 21. TARANTINO G., CITRO V, CONFORTI P, BALSANO C, CAPONE D. Is there a link between basal metabolic rate, spleen volume and hepatic growth factor levels in patients with obesity-related NAFLD? JCM. 2019; 8:1510.
- 22. XIAO G., ZHU S., XIAO X., YAN L., YANG J., WU G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatol. 2017; 66:1486–501.
- 23. CLEVELAND E., BANDY A., VANWAGNER LB. Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clin Liver Dis (Hoboken). 2018/04/20 ed. 2018;11:98–104.